These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9284751)

  • 1. Methimazole and propylthiouracil equally cross the perfused human term placental lobule.
    Mortimer RH; Cannell GR; Addison RS; Johnson LP; Roberts MS; Bernus I
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3099-102. PubMed ID: 9284751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The placental transfer of propylthiouracil, methimazole and carbimazole.
    Marchant B; Brownlie BE; Hart DM; Horton PW; Alexander WD
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1187-93. PubMed ID: 591614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism.
    Momotani N; Noh JY; Ishikawa N; Ito K
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3633-6. PubMed ID: 9360518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of developmental toxicity of propylthiouracil and methimazole.
    Mallela MK; Strobl M; Poulsen RR; Wendler CC; Booth CJ; Rivkees SA
    Birth Defects Res B Dev Reprod Toxicol; 2014 Aug; 101(4):300-7. PubMed ID: 24980470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hyperthyroidism during pregnancy and lactation.
    Azizi F; Amouzegar A
    Eur J Endocrinol; 2011 Jun; 164(6):871-6. PubMed ID: 21389085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
    Andersen SL; Olsen J; Wu CS; Laurberg P
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
    Hackmon R; Blichowski M; Koren G
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malformations following methimazole exposure in utero: an open issue.
    Ferraris S; Valenzise M; Lerone M; Divizia MT; Rosaia L; Blaid D; Nemelka O; Ferrero GB; Silengo M
    Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):989-92. PubMed ID: 14745920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
    Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
    J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicities associated with 1-month treatment with propylthiouracil (PTU) and methimazole (MMI) in male rats.
    Nambiar PR; Palanisamy GS; Okerberg C; Wolford A; Walters K; Buckbinder L; Reagan WJ
    Toxicol Pathol; 2014 Aug; 42(6):970-83. PubMed ID: 24067673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
    Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
    J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal transfer of methimazole and effects on thyroid hormone availability in embryonic tissues.
    Van Herck SL; Geysens S; Bald E; Chwatko G; Delezie E; Dianati E; Ahmed RG; Darras VM
    J Endocrinol; 2013 Jul; 218(1):105-15. PubMed ID: 23608220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of antithyroid drugs in pregnancy: the knowledge gaps.
    Koren G; Soldin O
    Ther Drug Monit; 2006 Feb; 28(1):12-3. PubMed ID: 16418686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
    Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of thioureylene antithyroid drugs: factors affecting intrathyroidal metabolism of propylthiouracil and methimazole in rats.
    Nakashima T; Taurog A; Riesco G
    Endocrinology; 1978 Dec; 103(6):2187-97. PubMed ID: 748042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secretion and transfer of the thyroid hormone binding protein transthyretin by human placenta.
    Mortimer RH; Landers KA; Balakrishnan B; Li H; Mitchell MD; Patel J; Richard K
    Placenta; 2012 Apr; 33(4):252-6. PubMed ID: 22264585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of antithyroid drugs with bovine serum albumin: electrophoretic and fluorimetric study.
    Chernov'yants MS; Dolinkin AO; Chernyshev AV; Khohlov EV; Golovanova EG
    J Pharm Sci; 2010 Mar; 99(3):1567-73. PubMed ID: 19774650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid function and intellectual development of infants nursed by mothers taking methimazole.
    Azizi F; Khoshniat M; Bahrainian M; Hedayati M
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3233-8. PubMed ID: 10999814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil.
    Shiroozu A; Taurog A; Engler H; Dorris ML
    Endocrinology; 1983 Jul; 113(1):362-70. PubMed ID: 6861708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.